WOBURN, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will host investor meetings at the following two conferences: BTIG Virtual Biotechnology Conference Dates: August 5-6, 2024 2024 Wedbush PacGrow Healthcare Conference Date: Tuesday, August 13, 2024 About Replimune Replimune Group, Inc., headquartere ...